Long-term efficacy, tolerability and overall survival in patients (pts) with unresectable or metastatic (U/M) PDGFRA D842V-mutant gastrointestinal stromal tumour (GIST) treated with avapritinib: NAVIGATOR phase I trial update Meeting Abstract
| Authors: | Jones, R. L.; Serrano, C.; von Mehren, M.; George, S.; Heinrich, M.; Kang, Y. K.; Schoeffski, P.; Cassier, P.; Mir, O.; Chawla, S. P.; Eskens, F. A.; Rutkowski, P.; Tap, W. D.; Zhou, T.; Roche, M.; Bauer, S. |
| Abstract Title: | Long-term efficacy, tolerability and overall survival in patients (pts) with unresectable or metastatic (U/M) PDGFRA D842V-mutant gastrointestinal stromal tumour (GIST) treated with avapritinib: NAVIGATOR phase I trial update |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S973 |
| Language: | English |
| ACCESSION: | WOS:000573469102208 |
| DOI: | 10.1016/j.annonc.2020.08.1847 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1621MO -- Source: Wos |
